Search Results - "SANDOW, Jürgen"

In vitro and in vivo correlation of buserelin release from biodegradable implants using statistical moment analysis by Schliecker, Gesine, Schmidt, Carsten, Fuchs, Stefan, Ehinger, Andreas, Sandow, Jürgen, Kissel, Thomas

“…Here we investigated the possibility to develop different levels of correlation between in vitro drug release profiles and in vivo pharmacokinetic parameters…”
Get full text

S- and C-glycopeptide derivatives of an LH-RH agonist by Michael, K, Wittmann, V, König, W, Sandow, J, Kessler, H

“…The S- and C-glycosylated nonapeptides 1 and 2 were synthesized as analogs of the non-glycosylated LH-RH agonist buserelin…”
Get more information

Duration of testosterone suppression after a 9.45 mg implant of the GnRH-analogue buserelin in patients with localised carcinoma of the prostate a 12-month follow-up study by PETTERSSON, Bill, VARENHORST, Eberhard, PETAS, Anssi, SANDOW, Jürgen

“…(1) To determine the duration of androgen deprivation after a single buserelin implant 9.45 mg in the neoadjuvant setting in combination with curative…”
Get full text

Duration of Testosterone Suppression after a 9.45mg Implant of the GnRH-Analogue Buserelin in Patients with Localised Carcinoma of the Prostate by Pettersson, Bill, Varenhorst, Eberhard, Petas, Anssi, Sandow, Jürgen

Get full text

Validation of excised bovine nasal mucosa as in vitro model to study drug transport and metabolic pathways in nasal epithelium by Schmidt, M C, Simmen, D, Hilbe, M, Boderke, P, Ditzinger, G, Sandow, J, Lang, S, Rubas, W, Merkle, H P

“…The present work aims at the validation of excised bovine nasal mucosa as an in vitro model to address transport and metabolism pathways relative to the nasal…”
Get more information

Circulating inhibitor of gonadotropin releasing hormone secretion by hypothalamic neurons in uremia by Daschner, Markus, Philippin, Bärbel, Nguyen, Trang, Wiesner, Rudolf J., Walz, Claudia, Oh, Jun, Sandow, Jürgen, Mehls, Otto, Schaefer, Franz

“…Circulating inhibitor of gonadotropin releasing hormone secretion by hypothalamic neurons in uremia. Previous studies have suggested a neuroendocrine defect…”
Get full text

Sex steroids used in hormonal treatment increase vascular procoagulant activity by inducing thrombin receptor (PAR-1) expression: Role of the glucocorticoid receptor by HERKERT, Olaf, KUHL, Herbert, SANDOW, Jurgen, BUSSE, Rudi, SCHINI-KERTH, Valérie B

“…The use of sex steroids in oral contraception or hormonal replacement therapy is associated with an increased risk of cardiovascular thromboembolic…”
Get full text

The regulation of LHRH action at the pituitary and gonadal receptor level: a review by Sandow, J

“…Luteinizing hormone releasing-hormone (LHRH) and its highly active agonists are under clinical investigation for the control of reproductive function and for…”
Get more information

Treatment of uterine fibroids with implants of gonadotropin-releasing hormone agonist: assessment by hysterography by Donnez, J, Schrurs, B, Gillerot, S, Sandow, J, Clerckx, F

“…The effect of a potent, subcutaneously injected gonadotropin-releasing hormone (GnRH analog) (Buserelin, Hoechst, Frankfurt/Main West Germany) on the size of…”
Get more information

The adjuvant effect of bacitracin on nasal absorption of gonadorelin and buserelin in rats by RAEHS, S. C, SANDOW, J, WIRTH, K, MERKLE, H. P

“…Nasal absorption of gonadorelin (luteinizing hormone-releasing hormone; LH-RH) and buserelin, an LH-RH agonist, was studied in anesthetized rats…”
Get full text

Investigations upon the mechanism of inhibition of spermatogenesis in the rat by a dimeric ethynodiol-testosterone ester by Born, H J, Hörster-Poschmann, P, Stoll, W, Sandow, J, Taubert, H D, Kuhl, H

“…The combination of androgens and progestogens has been shown to be a suitable male contraceptive. Previous experiments revealed that injection of a dimeric…”
Get more information

Serum concentration and urinary excretion of the luteinizing hormone-releasing hormone agonist buserelin in patients with endometriosis by Kiesel, L, Sandow, J, Bertges, K, Jerabek-Sandow, G, Trabant, H, Runnebaum, B

“…We studied the pharmacokinetics of iv and intranasally administered buserelin, a LHRH agonist peptide, in 14 women with endometriosis. Serum and urinary…”
Get more information

Degradation of luteinizing hormone - releasing hormone and analogs by adenohypophyseal peptidases by Horsthemke, B, Knisatschek, H, Rivier, J, Sandow, J, Bauer, K

Get more information

Pituitary gonadotropin inhibition by a highly active analog of luteinizing hormone-releasing hormone by Sandow, J, Von Rechenberg, W, Jerzabek, G, Stoll, W

“…Chronic treatment with highly active analogs of luteinizing hormone (LH)-releasing hormone (LH-RH) induces "paradoxical" antifertility effects. Intact male…”
Get more information

New analogues of secretin by König, W, Bickel, M, Wissmann, H, Sandow, J

“…For the evaluation of structure/activity relationships, some porcine secretin analogues, modified in the N-terminus, have been synthesized by segment…”
Get more information

Treatment of cryptorchidism with pernasal gonadotropin-releasing hormone therapy by Happ, J, Kollmann, F, Krawehl, C, Neubauer, M, Krause, U, Demisch, K, Sandow, J, Von Rechenberg, W, Beyer, J

“…Twenty-five boys between 1 and 10 years of age with unilateral or bilateral cryptorchidism were treated with 200 microgram of gonadotropin-releasing hormone…”
Get more information

Synthesis and properties of [11-serine]alpha-melanotropin by Geiger, R, Sandow, J, Kastin, A J

“…[Ser11]alpha-melanotropin has been prepared and its melanotropic activity compared with that of alpha-melanotropin and several known analogues. Full activity…”
Get more information

Administration of nasal Buserelin as compared with subcutaneous Buserelin implant for endometriosis by Donnez, J, Nisolle-Pochet, M, Clerckx-Braun, F, Sandow, J, Casanas-Roux, F

“…One hundred infertile patients with laparoscopically confirmed ovarian endometriosis were treated with either intranasal (IN) Buserelin (Hoechst, AG, Frankfurt…”
Get more information

Suppression of follicular maturation by infusion of a luteinizing hormone-releasing hormone agonist starting during the late luteal phase in the stumptailed macaque monkey by Fraser, H M, Sandow, J

“…The effect of continuous administration of an LHRH agonist for 14 days on follicular estradiol secretion was studied in adult female stumptailed macaque…”
Get more information

Long-term suppression of ovarian function by a luteinizing-hormone releasing hormone agonist implant in patients with endometriosis by Fraser, H M, Sandow, J, Cowen, G M, Lumsden, M A, Haining, R, Smith, S K

“…Ten endometriosis patients received luteinizing hormone releasing hormone (LH-RH) agonist (buserelin) implant injections (6.6 mg subcutaneously) at days 0, 42,…”
Get more information